Compass Therapeutics, Inc. (CMPX)
0.993
+0.01
(+0.98%)
USD |
NASDAQ |
Oct 09, 16:00
0.9912
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Cash from Investing (Quarterly) : -4.977M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.977M |
| March 31, 2026 | 38.43M |
| December 31, 2025 | -3.378M |
| September 30, 2025 | -95.16M |
| June 30, 2025 | -6.36M |
| March 31, 2025 | 11.59M |
| December 31, 2024 | 15.37M |
| September 30, 2024 | 29.02M |
| June 30, 2024 | 6.483M |
| March 31, 2024 | -4.099M |
| December 31, 2023 | 6.314M |
| September 30, 2023 | 17.05M |
| June 30, 2023 | -0.667M |
| March 31, 2023 | 4.269M |
| December 31, 2022 | -46.65M |
| Date | Value |
|---|---|
| September 30, 2022 | 1.18M |
| June 30, 2022 | -105.54M |
| March 31, 2022 | -0.193M |
| December 31, 2021 | -0.776M |
| September 30, 2021 | -0.367M |
| June 30, 2021 | -0.614M |
| March 31, 2021 | -0.013M |
| December 31, 2020 | 0.006M |
| September 30, 2020 | -0.007M |
| June 30, 2020 | 0.051M |
| March 31, 2020 | -0.012M |
| December 31, 2019 | -0.185M |
| September 30, 2019 | -0.027M |
| June 30, 2019 | 0.065M |
| March 31, 2019 | -0.319M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | 109.43M |
| Capricor Therapeutics, Inc. | -48.76M |
| Ardelyx, Inc. | 22.66M |
| Biomea Fusion, Inc. | 0.00 |
| ARS Pharmaceuticals, Inc. | 41.57M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.74M |
| Free Cash Flow | -56.38M |
| Free Cash Flow Per Share (Quarterly) | -0.0798 |
| Free Cash Flow to Equity (Quarterly) | -14.76M |
| Free Cash Flow to Firm (Quarterly) | -14.91M |
| Free Cash Flow Yield | -31.24% |